Literature DB >> 9809441

Isolation and chromosomal mapping of human glycogen synthase kinase-3 alpha and -3 beta encoding genes.

P C Shaw1, A F Davies, K F Lau, M Garcia-Barcelo, M M Waye, S Lovestone, C C Miller, B H Anderton.   

Abstract

Glycogen synthase kinase-3 (GSK-3) is a serine-threonine kinase that exists as two isoforms, alpha and beta, encoded by separate genes. Phosphorylation targets include a variety of cytoplasmic and nuclear proteins. Recent studies found that neurofilaments, amyloid precursor protein, and tau proteins are substrates of GSK-3 and that aberrant phosphorylation of these proteins is implicated in pathologies of the nervous system. To analyse the organisation of these two genes, a YAC library was screened by polymerase chain reaction, using primers specific for human GSK-3 alpha and GSK-3 beta cDNA. Two clones, 220 and 285 kb in size, containing the complete GSK-3 alpha coding sequence, and two clones, 365 and 285 kb in size, containing the 5' coding sequence of GSK-3 beta, were isolated. By somatic cell hybrid panel DNA amplification and radiation hybrid mapping, GSK-3 alpha was found to be located at 19q13.2. On the other hand, by somatic cell hybrid panel DNA amplification and fluorescence in situ hybridisation using the 285-kb YAC clone, GSK-3 beta was mapped to 3q13.3.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9809441

Source DB:  PubMed          Journal:  Genome        ISSN: 0831-2796            Impact factor:   2.166


  9 in total

1.  GSK-3beta gene expression in human postmortem brain: regional distribution, effects of age and suicide.

Authors:  Ghanshyam N Pandey; Yogesh Dwivedi; Hooriyah S Rizavi; Tara Teppen; Gabor L Gaszner; Rosalinda C Roberts; Robert R Conley
Journal:  Neurochem Res       Date:  2008-06-28       Impact factor: 3.996

2.  Effect of naringenin on brain insulin signaling and cognitive functions in ICV-STZ induced dementia model of rats.

Authors:  Wenqing Yang; Jing Ma; Zheng Liu; Yongliang Lu; Bin Hu; Huarong Yu
Journal:  Neurol Sci       Date:  2013-12-12       Impact factor: 3.307

Review 3.  Perspectives on Wnt Signal Pathway in the Pathogenesis and Therapeutics of Chronic Obstructive Pulmonary Disease.

Authors:  Jiao Qu; Li Yue; Jian Gao; Hongwei Yao
Journal:  J Pharmacol Exp Ther       Date:  2019-04-05       Impact factor: 4.030

Review 4.  GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder.

Authors:  Michael K Rowe; Charlotte Wiest; De-Maw Chuang
Journal:  Neurosci Biobehav Rev       Date:  2007-03-15       Impact factor: 8.989

5.  Identification of porcine glycogen synthase kinase 3α (GSK-3α) gene and its association with carcass traits.

Authors:  Linjie Wang; Yan Wang; Tao Zhong; Li Li; Hongping Zhang; Yuanzhu Xiong
Journal:  Mol Cell Biochem       Date:  2013-01-29       Impact factor: 3.396

6.  GSK3 and Alzheimer's Disease: Facts and Fiction….

Authors:  Anna Kremer; Justin V Louis; Tomasz Jaworski; Fred Van Leuven
Journal:  Front Mol Neurosci       Date:  2011-08-26       Impact factor: 5.639

7.  Haplotype analysis of GSK-3β gene polymorphisms in bipolar disorder lithium responders and nonresponders.

Authors:  Kazuhiko Iwahashi; Daisuke Nishizawa; Shin Narita; Maki Numajiri; Ohoshi Murayama; Eiji Yoshihara; Yuuya Onozawa; Kenta Nagahori; Fumihiko Fukamauchi; Kazutaka Ikeda; Jun Ishigooka
Journal:  Clin Neuropharmacol       Date:  2014 Jul-Aug       Impact factor: 1.592

Review 8.  Pharmacological Treatments Inhibiting Levodopa-Induced Dyskinesias in MPTP-Lesioned Monkeys: Brain Glutamate Biochemical Correlates.

Authors:  Nicolas Morin; Thérèse Di Paolo
Journal:  Front Neurol       Date:  2014-08-05       Impact factor: 4.003

Review 9.  GSK3β: a plausible mechanism of cognitive and hippocampal changes induced by erythropoietin treatment in mood disorders?

Authors:  Becky Inkster; Gwyneth Zai; Gemma Lewis; Kamilla W Miskowiak
Journal:  Transl Psychiatry       Date:  2018-10-11       Impact factor: 6.222

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.